| Biomarker ID | 783 |
| PMID | 21993000 |
| Year | 2011 |
| Biomarker | Thiobarbituric acid reactive substances (TBARS) |
| Biomarker Basis | Concentration Based (nmol/ml) |
| Biomolecule | Protein |
| Source | Plasma |
| Subjects | Humans |
| Regulation | Upregulated in PCA (GS<7, GS=7, GS>7) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Controls Vs GS<7 Vs GS =7 Vs GS>7 |
| Type of Biomarker | Prognostic |
| Cohort | 50 controls and 50 patients with PCA were chosen for the study. 20 patients has GS ≤6, 21 had GS=7 and 14 had GS ≥8 |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 (Controls Vs GS<7) & (Controls Vs GS=7) & (Controls Vs GS>7) |
| Method Used | NA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |